Embla Medical hf. (CPH:EMBLA)
28.30
+0.10 (0.35%)
Jul 28, 2026, 4:59 PM CET
Embla Medical Revenue
Embla Medical had revenue of $258.57M USD in the quarter ending June 30, 2026, with 11.25% growth. This brings the company's revenue in the last twelve months to $984.45M, up 12.70% year-over-year. In the year 2025, Embla Medical had annual revenue of $928.69M with 8.63% growth.
Revenue (ttm)
$984.45M
Revenue Growth
+12.70%
P/S Ratio
1.87
Revenue / Employee
$218.77K
Employees
4,500
Market Cap
12.05B DKK
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 928.69M | 73.80M | 8.63% |
| Dec 31, 2024 | 854.89M | 69.21M | 8.81% |
| Dec 31, 2023 | 785.68M | 67.03M | 9.33% |
| Dec 31, 2022 | 718.65M | -19.00K | - |
| Dec 31, 2021 | 718.67M | 89.17M | 14.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 327.80B |
| Coloplast | 28.05B |
| H. Lundbeck | 25.52B |
| Genmab | 25.29B |
| Demant | 22.97B |
| GN Store Nord | 16.60B |
| Zealand Pharma | 9.24B |
| Ambu A/S | 6.10B |
Embla Medical News
- 7 days ago - Embla Medical Slides: Investor presentation - Filings
- 7 days ago - Embla Medical Earnings Call Transcript: Q2 2026 - Transcripts
- 7 days ago - Embla Medical Quarterly report: Q2 2026 - Filings
- 7 days ago - Embla Medical Slides: Q2 2026 - Filings
- 7 days ago - Embla Medical Earnings Call Transcript: Q2 2026 - Transcripts
- 7 days ago - Embla Medical Quarterly report: Q2 2026 - Filings
- 7 days ago - Embla Medical Slides: Q2 2026 - Filings
- 4 weeks ago - Embla Medical Slides: R&D presentation - Filings